Letters NICE guidance on ADHD

Diversion and abuse of methylphenidate in light of new guidance

BMJ 2008; 337 doi: http://dx.doi.org/10.1136/bmj.a2287 (Published 28 October 2008) Cite this as: BMJ 2008;337:a2287
  1. Harry R Sumnall, reader in substance use,
  2. Kerry Woolfall, senior researcher,
  3. Jon Cole, reader, Department of Psychology,
  4. Adam Mackridge, lecturer in pharmacy practice,
  5. Jim McVeigh, reader in substance use epidemiology
  1. 1Centre for Public Health, Liverpool John Moores University, Liverpool L3 2EZ
  1. h.sumnall{at}ljmu.ac.uk

    Psychostimulants were approved for use in children by the National Institute for Health and Clinical Excellence (NICE) in 2006, but, for the first time, methylphenidate, atomexetine, and dexamphetamine have now been recommended for adult pharmacotherapy.1 We want to endorse NICE’s advice: healthcare professionals should be aware of the potential of these drugs for misuse and diversion. Recent data show great variation …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe